EGFR and head and neck squamous cell carcinoma: However, a previous study showed that ROS stimulated angiogenesis and tumor progression by reducing the expression of CXCL14 via EGFR/MEK/ERK signaling pathway in HNSCC cells (Maehata et al., 2010).